“showed a trend”

PL fractures treated with all-lateral fixation showed a trend toward increased rotational instability or malunion (23.8% versus 1.3%; p = 0.073).

At 6-months follow-up ( Table 4 B), we found that ARMS2 (rs10490924) G allele is associated with increased BCVA improvement (OR = 1.95; 95%CI = 0.98–3.83; p = 0.037) and showed a trend for the association with worsening ( p = 0.073) compared to the T allele.

The median age did not differ between cases and controls (cases: 64 years, range 18–88, vs controls: 67.5 years, range 23–90; Mann-Whitney test P = 0.46), although female sex showed a trend toward increased frequency in cases (66.4% vs 54.1%, P = 0.073).

Similar findings were observed in a post hoc analysis of the Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides and Impact on Global Health Outcomes (AIM-HIGH) Trial among 522 subjects (15%) who were in both the highest TG [>2.24 mmol/L (198 mg/dL)] and lowest HDL-C [<0.85 mmol/L (33 mg/dL)] tertiles, where extended-release niacin showed a trend toward benefit [hazard ratio (HR) = 0.74, P = 0.073]. 27 Clearly, additional outcomes studies in patients optimally treated with statins and pre-selected for hypertriglyceridaemia are needed.

preoperative biliary drainage direct surgery resectable periampullary cancer obstructive jaundice postoperative outcomes Faculty of Medicine, Prince of Songkla University 10.13039/501100010804 In the univariable analyses exploring the factors associated with 1-year mortality ( Figure 2 ), PBD showed a trend towards a lower 1-year mortality rate with an odds ratio (OR) of 0.42 (95%CI: 0.16-1.08, p=0.073).

34.0 months, p = 0.016, HR = 0.533, 95% CI: 0.332‐0.855, Figure S6E , Supporting Information) and showed a trend toward improved RFS (29.0 months vs. 17.0 months, p = 0.073, HR = 0.661, 95% CI: 0.428‐1.021, Figure S6F , Supporting Information).

Predictors of Treatment Response Using the Exacerbation Reduction Criterion In the bivariate analysis, the variable that showed a trend towards a reduction in exacerbations was the absence of exacerbations in the previous year ( p = 0.073) ( Table S22 ).

13.9%; P = 0.047), and biopsied primary tumor specimens showed a trend for an increased discordant rate when compared with resected primary tumor specimens (40.0% vs. 15.8%; P = 0.073).

Paired t tests on the voice and speech aspects for the prosthetic speakers in the Control and HME group, showed a trend for the prosthetic speakers to report more fluent speech with HME use ( P = 0.073).

A lung function based polygenic risk score was associated with annual change in %LAA-950 ( P = 4.03e-02) and with baseline measures of quantitative emphysema ( P < 1e-03) and showed a trend toward association with annual change in ALD ( P = 7.31e-02).

LBP also showed a trend towards correlating with DAS 28-3 in the subgroup of RA patients that used tobacco products ( r = 0.4599; p = 0.0731), while a moderate correlation between serum SP-D and disease duration ( r = 0.4181; p = 0.0073), as well as weak negative correlations of this biomarker with I-FABP ( r = −0.2869; p = 0.0123) and LPS ( r = −0.3287; p = 0.0411) were also noted. 3.2.

The frequency of T-bet neg Eomes neg MAIT cells showed a trend towards a decrease during this culture (n = 9, p = 0.0732; Fig 7C ).

Analyses of games missed showed a trend toward offensive players missing more games than defensive players ( P = .0732).

At later imaging sessions, this correlation no longer reached significance, but still showed a trend at 2 years after treatment, r (17) = 0.420, p = 0.0732, and 2.5 years after treatment, r (14) = 0.456, p = 0.0756.

Moreover, the genotypes did not differ did in terms of their variability of RTs in first test part ( p = 0.36), but showed a trend for a difference in standard deviations during the last test part ( p = 0.0734).

CD8 + T cells showed a trend towards increased numbers in the primary tumor with tilorone treatment relative to the vehicle cohort ( p = 0.0734, Supplemental Fig. 5 D), as did the number of CD69 + /CD8 + T cells compared to the doxorubicin group ( p = 0.0201) and the combination treatment group ( p = 0.08, Supplemental Fig. 5 E, F).

Finally, we found a high correlation of TGFBi and POSTN levels in all pooled experiments with pooled genotypes and treatments (R 2 = 0.266, r = 0.52, p < 0.0001) ( Figure 7 E), which was significant in all genotypes except Stab2−/− , which showed a trend toward a moderate correlation (R 2 = 0.13, r = 0.36, p = 0.0734) ( Figure 7 F). 3.

However, by 7 dpi, ISG15 −/− mice already showed a trend toward increased bacterial burden compared to WT mice (p = 0.0734), although the difference did not reach statistical significance ( Fig 4c ).

Similarly, patients with HER2-positive tumors showed a trend toward an increased risk compared with those with HER2-negative tumors (OR = 1.697; 95% CI, 0.951–3.029; p = 0.0734).

CD169-Cre x TLR7 fl/fl mice showed a trend of reduced VSV infection in dLN as compared to Wt mice ( p = 0.0735) although the reduction was less pronounced compared to TLR7 −/− mice ( Figure 7C ).

The ConA group showed a trend of reduced cell viability by 15.2% ( p = 0.0738).

Nonetheless, participants showed a trend for successfully upregulating based on the linear regression results (Intercept coefficient = −0.103, R 2 = 0.272 and p value = 0.0739).

Compared to the low-risk group, the incidence rate of SARS-CoV-2 pneumonia was significantly higher in the moderate-risk group (1.47-fold increase; 95% confidence intervals [CI]: 1.07–2.01, p = 0.017) and showed a trend toward being higher in the high-risk group (1.37-fold increase; 95% CI: 0.90–1.93, p = 0.074) ( Table 3 ).

In a stage-adjusted Cox model, strong TLR4 expression showed a trend to association with a better prognosis; in the tumour front, the HR for overall survival was 1.8 ( P = 0.074, 95%CI: 0.9-3.3), and in the tumour bulk, it was 1.7 ( P = 0.059, 95%CI: 1.0-3.1).

In the TCGA BLCA test data set ( n = 121), the miRNA signature showed a trend for PFS (HR = 1.75, 95% CI 0.94–3.27, p = 0.074) but was not prognostic for OS (HR = 1.53, 95% CI 0.84–2.76, p = 0.16) (Fig. 2b, d and Supplementary Table 6 ).